Rheumatology NewsObesity may drive symptom severity in rheumatoid arthritisJuly 7, 2014PainRheumatoid Arthritis
Rheumatology NewsObesity may drive symptom severity in rheumatoid arthritisJuly 7, 2014PainRheumatoid Arthritis
Rheumatology NewsVIDEO: Sarilumab shows RA safety, efficacy in phase III trialJune 26, 2014Rheumatoid Arthritis
Rheumatology NewsHigher risk of death seen with oral steroids in RA interstitial lung diseaseJune 19, 2014Rheumatoid Arthritis
Rheumatology NewsVIDEO: Gene profiling could signal start of personalized medicine in RAJune 19, 2014Rheumatoid Arthritis
Rheumatology NewsInternational RA risk tool for CVD comes closer to realityJune 13, 2014Rheumatoid Arthritis
Rheumatology NewsSarilumab shown safe, effective for RA in phase III trialJune 13, 2014Rheumatoid Arthritis
Rheumatology NewsBiosimilars match infliximab, etanercept for RA treatmentJune 11, 2014Rheumatoid Arthritis
Rheumatology NewsNaloxegol cut opioid-associated constipation without impairing pain reliefJune 4, 2014PainOrthopedicsOsteoarthritisRheumatoid Arthritis
Rheumatology NewsFDA approves blood test for membranous glomerulonephritisMay 30, 2014Lupus & Connective Tissue DiseasesRheumatoid Arthritis
Rheumatology NewsRA’s heterogeneity poses challenge to ‘personalized medicine’ May 28, 2014Rheumatoid Arthritis
Rheumatology NewsTriple therapy topped monotherapy in early rheumatoid arthritisMay 16, 2014Rheumatoid Arthritis
Rheumatology NewsCelebrex cost high in United States, low in CanadaMay 13, 2014PainRheumatoid ArthritisBusiness of Medicine
Rheumatology NewsHumira, Enbrel costs highest in the United StatesMay 13, 2014Rheumatoid ArthritisBusiness of Medicine
